Search results
Results From The WOW.Com Content Network
Menopause, the biological impact of a surgical procedure with anesthesia, medications prescribed in addition to the chemotherapy, genetic predisposition, hormone therapy, emotional states (including anxiety, depression and fatigue), comorbid conditions and paraneoplastic syndrome may all co-occur and act as confounding factors in the study or ...
Brain fog during menopause could also "be related to changes in the hypothalamus at the base of the brain, which we know occurs from the decreasing levels of estrogen," Minkin says.
Menopause is a natural decline in the ovarian function of women who reach the age between 45 and 54 years. "About 25 million women pass through menopause worldwide each year, and it has been estimated that, by the year 2030, the world population of menopausal and postmenopausal women will be 1.2 billion, with 47 million new entrants each year."
One that might fall into the latter category is menopause brain, which is brain fog—a non-medical term for symptoms like forgetfulness and difficulty focusing—that happens during perimenopause ...
For people with brain tumors, radiation can be an effective treatment because chemotherapy is often less effective due to the blood–brain barrier. [ citation needed ] Unfortunately for some patients, as time passes, people who received radiation therapy may begin experiencing deficits in their learning, memory, and spatial information ...
Medically-induced menopause is a treatment that uses medication to put a woman into menopause, explains Tracy O’Connor, M.D., a breast oncologist at Moffitt Cancer Center. “It’s often used ...
Tamoxifen is also used to treat hormonally-responsive breast cancer, but it does so by interfering with the estrogen receptor. However, letrozole is effective only in post-menopausal women, in whom estrogen is produced predominantly in peripheral tissues (i.e. in adipose tissue, like that of the breast) and a number of sites in the brain. [9]
Inhibits DNA and to a lesser extent RNA synthesis, produces single and double strand breaks in DNA possibly by free radical formation. Germ cell tumours, squamous cell carcinoma, pancreatic cancer, non-Hodgkin's, pleural sclerosing and Hodgkin's lymphoma. Pulmonary toxicity, hypersensitivity, scleroderma and Raynaud's phenomenon. Bortezomib: IV, SC